Scientists just took a big, “very positive” step towards developing what could be the first ‘universal cancer vaccine’.
The results from early trials in humans, along with research in mice, have just been published, and they suggest that the new technique could be used to activate patients’ immune systems against any type of tumour, no matter where it is in the body.
Unlike the vaccines we’re familiar with, this potential vaccine would be given to patients who already have cancer, rather than those at risk of getting it. It basically works by shooting tiny ‘darts’ containing pieces of RNA extracted from the patient’s cancer cells at the body’s own immune system, convincing them to launch an all-out attack on any tumours they come across.
By just changing the RNA inside those darts, the team can, in theory, mobilise the immune system against any kind of cancer. “[Such] vaccines are fast and inexpensive to produce, and virtually any tumour antigen can be encoded by RNA,” the team, led by researchers at Johannes Gutenberg University of Mainz in Germany, reports in Nature.
“Thus, the nanoparticulate RNA immunotherapy approach introduced here may be regarded as a universally applicable novel vaccine class for cancer immunotherapy.”
But until now, researchers have mostly done this by genetically engineering special, cancer-targeting immune cells in the lab, and then injecting them back into a patient – which is a time-consuming and expensive process.
The difference with this technique is that the vaccine is made in the lab, and it introduces the cancer DNA into the immune cells within the body, which is a lot less invasive. It also means that the vaccine can be tweaked to hunt a range of cancer types.
The Latest on: Universal cancer vaccine
via Google News
The Latest on: Universal cancer vaccine
- mRNA vaccines: How they work, and what they might mean for the futureon May 13, 2021 at 9:37 am
Vaccines are often described as one of the greatest public health interventions in recent history, based on the profound effect that they have had in decreasing global morbidity and mortality.
- Covid Live Updates: C.D.C. Says Vaccinated People Can Go Maskless in Most Placeson May 13, 2021 at 7:54 am
The world’s first mass inoculation effort in youngsters began after the U.S. government green lit the use of the Pfizer-BioNTech vaccine in children aged 12 to 15. It also underscored the widening ...
- Catholic Perspectives in Short Supply at Vatican Health Conferenceon May 12, 2021 at 11:58 am
No effort was made to communicate the Church’s call for vaccines made without using abortion-derived tissues, or to present Church wisdom on a number of issues discussed at the event.
- Ultimovacs Publishes Positive Long-term UV1 Data from Phase I Malignant Melanoma Combination Study in Frontiers in Immunologyon May 11, 2021 at 8:47 am
Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, today announced the publication in Frontiers in Immunology ...
- Ultimovacs ASA: First Quarter 2021 Result Presentationon May 11, 2021 at 3:05 am
Ultimovacs ASA ("Ultimovacs", ticker ULTI), a pharmaceutical company developing novel immunotherapies against cancer, announces its first quarter 2021 results today. A presentation by the Company's ...
- Vaccines Bring Us Closer to a Fairer Worldon May 10, 2021 at 10:00 am
The COVID-19 pandemic stands as a stark reminder of how quickly infectious diseases can spread without vaccines, and the damage they can cause to health, economic and social systems. Although the ...
- Ultimovacs to Discuss ASCO UV1 Phase I Data in Webcast and Investor Meetingson May 10, 2021 at 8:06 am
Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, today announced that its management team will discuss data from the abstract of a poster ...
- Covid was just the start. Next we'll make a vaccine for canceron May 9, 2021 at 9:00 pm
Scientists are learning to harness a 'game-changing' technique that has the potential to defeat a range of humanity's deadliest foes ...
- Concern over vaccine effectiveness on variantson May 9, 2021 at 3:07 am
A Covid-19 variant spreading in India is more contagious and may be dodging vaccine protections, contributing to the country's explosive outbreak, the World Health Organization's chief scientist has ...
- In fight against COVID variants some firms target T cell jabson May 8, 2021 at 2:54 am
Getting COVID vaccines into the arms of the world's population is an international priority—but will today's jabs stay effective against virus variants that are spreading across the globe?
via Bing News